|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Flow and transport through clay membrane barriers显示文摘 | MICHAEL A MALUSIS CHARLES D SHACKELFORD HAROLD W OLSEN | 2003 | Engineering Geology2003，70，： | 1 |
| 2 | Changes in race structure of Gpi 100:111:122 and Gpi 100: 100:111 populations of Phytophthora infestans in Canada during 1997 - 1999 显示文摘 | FOUAD D HAROLD W BUD P | 2004 | Canadian Journal of Plant Pathology2004，26，4： | 1 |
| 3 | Biochar: A Synthesis of Its Agronomic Impact beyond Carbon Sequestration显示文摘 | Spokas Kurt A Cantrell Keri B M Novak Jeffrey Archer David W Ippolito James A Collins Harold P Boateng Akwasi A Lima Isabel M Lamb Marshall C McAloon Andrew J Lentz Rodrick D Nichols Kristine A | 2012 | Journal of Environmental Quality2012，，4： | 1 |
| 4 | Ultra-light weight proppant development yields exciting new opportunities in hydraulic fracturing design 显示文摘 | William D W Harold D B Allan R R | 2003 | Society of Petroleum Engineers2003，，： | 1 |
| 5 | Thermal and alkaline denaturation of bovine 13-casein 显示文摘 | Phoebe X Q Edward D W Harold M F | 2004 | The Protein Journal2004，23，6： | 1 |
| 6 | High strength,ultra-lightweight proppant lends new dimensions to hydraulic fracturingapplications显示文摘 | Allan R R Harold D B William D W | 2003 | SPE 843082003，，： | 1 |
| 7 | Transcrip?tional analysis of novel hormone receptors PGRMCI and PGRMC2 as potential biomarkers of breast adenocarcinoma staging显示文摘 | Causey M W Huston LJ Harold D M | 2011 | J Surg Res2011，171，2： | 1 |
| 8 | Biodiversity and ecosystem services science for a sustainable planet: the DIVERSITAS vision for 2012–20显示文摘 | Anne Larigauderie Anne-Hélène Prieur-Richard Georgina M Mace Mark Lonsdale Harold A Mooney Lijbert Brussaard David Cooper Wolfgang Cramer Peter Daszak Sandra Díaz Anantha Duraiappah Thomas Elmqvist Daniel P Faith Louise E Jackson Cornelia Krug Paul W Lead | 2012 | Current Opinion in Environmental Sustainability2012，，1： | 1 |
| 9 | Ground-water tracers-A short review显示文摘 | STANLEY N D GLENN M T HAROLD W B | 1980 | Ground Water1980，18，1： | 1 |
| 10 | Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans显示文摘 | JENNY T RONALD L P HAROLD W D | 2010 | Diabetes2010，59，9： | 1 |
| 11 | Biochar: A Synthesis of Its Agronomic Impact beyond Carbon Sequestration显示文摘 | Spokas Kurt A Cantrell Keri B M Novak Jeffrey Archer David W Ippolito James A Collins Harold P Boateng Akwasi A Lima Isabel M Lamb Marshall C McAloon Andrew J Lentz Rodrick D Nichols Kristine A | 2012 | Journal of Environmental Quality2012，，4： | 1 |
| 12 | Clinical and therapeutic features of polymorphous low - grade ade- nocarcinoma显示文摘 | Steven D Vincent Harold L Hammond Michael W Finkelstein | 1994 | Oral Surg Oral Med Oral Pathol1994，1，77： | 1 |
| 13 | Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer显示文摘Pancreatic cancer is one of the deadliest of cancers with a five-year survival of roughly 8%.Current therapies are:surgery,radiation and chemotherapy.Surgery is curative only if the cancer is caught very early,which is rare,and the latter two modalities are only marginally effective and have significant side effects.We have developed a nanosome comprised of the lysosomal protein,saposin C(SapC)and the acidic phospholipid,dioleoylphosphatidylserine(DOPS).In the acidic tumor microenvironment,this molecule,SapC-DOPS,targets the phosphatidylserine cancer-biomarker which is predominantly elevated on the surface of cancer cells.Importantly,SapC-DOPS can selectively target pancreatic tumors and metastases.Furthermore,SapC-DOPS has exhibited an impressive safety profile with only a few minor side effects in both preclinical experiments and in phase I clinical trials.With the dismal outcomes for pancreatic cancer there is an urgent need for better treatments and SapC-DOPS is a good candidate for addition to the oncologist’s toolbox. | Harold W Davis Ahmet Kaynak Subrahmanya D Vallabhapurapu Xiaoyang Qi | 2021 | World Journal of Gastrointestinal Oncology2021，13，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员